Bank of New York Mellon Corp - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25,302,374
+252.1%
500,245
+225.0%
0.01%
+200.0%
Q2 2023$7,186,898
+53.2%
153,928
+25.6%
0.00%
+100.0%
Q1 2023$4,690,370
-39.1%
122,592
-12.7%
0.00%
-50.0%
Q4 2022$7,698,413
+100.3%
140,482
+24.4%
0.00%
+100.0%
Q3 2022$3,844,000
+372.2%
112,890
+31.2%
0.00%
Q2 2022$814,000
-29.6%
86,077
+5.5%
0.00%
Q1 2022$1,157,000
-30.6%
81,582
+3.5%
0.00%
Q4 2021$1,667,000
-3.3%
78,789
+2.2%
0.00%
Q3 2021$1,724,000
-0.3%
77,114
+10.6%
0.00%
Q2 2021$1,730,000
+9.1%
69,721
+27.6%
0.00%
Q1 2021$1,585,000
+2.0%
54,648
-9.3%
0.00%
Q4 2020$1,554,000
-28.8%
60,232
-15.1%
0.00%
-100.0%
Q3 2020$2,184,000
+115.4%
70,928
+74.3%
0.00%
Q2 2020$1,014,000
+74.2%
40,688
+48.2%
0.00%
Q1 2020$582,000
+38.2%
27,456
+44.7%
0.00%
Q4 2019$421,000
+68.4%
18,968
+73.0%
0.00%
Q3 2019$250,00010,9670.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Skorpios Trust 1,621,829$75,723,19632.88%
COMMODORE CAPITAL LP 1,675,000$78,205,7508.79%
Ghost Tree Capital, LLC 360,000$16,808,4005.55%
Boxer Capital, LLC 1,676,733$78,2873.63%
SILVERARC CAPITAL MANAGEMENT, LLC 241,357$11,268,9583.49%
Atlas Venture Life Science Advisors, LLC 594,251$27,745,5793.45%
SILVERARC CAPITAL MANAGEMENT, LLC 236,500$11,039,8203.42%
Logos Global Management LP 520,000$24,278,8003.30%
Redmile Group, LLC 1,811,672$84,586,9663.25%
Yiheng Capital Management, L.P. 1,201,591$56,102,2843.03%
View complete list of AKERO THERAPEUTICS INC shareholders